Topamax Recalled for Odor

The LA Times reports that 57,000 bottles of the anti seizure drug Topamax has been recalled due to an “uncharacteristic odor.”   The smell is thought be caused by TBA, a chemical used in treating wood and may have come from the wood pallets used in shipping and storage.  Last December, Pfizer recalled a lot of Lipitor for the exact same problem.

“Such contamination creates the smell but leads to only “minimal health risks,” the FDA says, adding that a few patients reported gastrointestinal symptoms.”

In the meantime, the FDA has recommended drug manufacturers not store medications near wood treated with this preservative.

Bookmark and Share

Comments are closed.